nach oben

AIDS and Behavior

Erschienen in:

01.01.2013 | Substantive Review

Predictors of Late Presentation for HIV Diagnosis: A Literature Review and Suggested Way Forward

verfasst von: Abraham Mukolo, Raquel Villegas, Muktar Aliyu, Kenneth A. Wallston

Erschienen in: AIDS and Behavior | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Early commencement of antiretroviral treatment can be beneficial and economical in the long run. Despite global advances in access to care, a significant proportion of adults presenting at HIV/AIDS care facilities present with advanced HIV disease. Understanding factors associated with late presentation for HIV/AIDS services is critical to the development of effective programs and treatment strategies. Literature on factors associated with late presentation for an HIV diagnosis is reviewed. Highlighted is the current emphasis on socio-demographic factors, the limited exploration of psychosocial correlates, and inconsistencies in the definition of late presentation that make it difficult to compare findings across different studies. Perspectives based on experiences from resource limited settings are underreported. Greater exploration of psychosocial predictors of late HIV diagnosis is advocated for, to guide future intervention research and to inform public policy and practice targeted at ‘difficult to reach’ populations.

Leombruni P, Fassino S, Lavagnino L, Orofino G, Morosini P, Picardi A. The role of anger in adherence to highly active antiretroviral treatment in patients infected with HIV. Psychother Psychosom. 2009;78:254–7.PubMedCrossRef

When To Start Consortium, Sterne JA, May M, Costagliola D, de Wolf F, Phillips AN, et al. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet. 2009;373:1352–63.

Larson BA, Brennan A, McNamara L, Long L, Rosen S, Sanne I, et al. Lost opportunities to complete CD4+ lymphocyte testing among patients who tested positive for HIV in South Africa. Bull World Health Organ. 2010;88:675–80.PubMedCrossRef

Rosen S, Fox M, Larson B. From HIV testing to treatment initiation: the missing link. In: 18th Conference on retroviruses and opportunistic infections (CROI), Boston, MA; 2011.

Manga NM, Diop SA, Ndour CT, Dia NM, Mendy A, Coudec M, et al. Late diagnosis of HIV infection in the Fann, Dakar clinic of infectious diseases: testing circumstances, therapeutic course of patients, and determining factors. Med Mal Infect. 2009;39:95.PubMedCrossRef

Harling G, Orrell C, Wood R. Healthcare utilization of patients accessing an African national treatment program. BMC Health Serv Res. 2007;7:80.PubMedCrossRef

Sall L, Salamon E, Allgulander C, Owe-Larsson B. Psychiatric symptoms and disorders in HIV infected mine workers in South Africa. A retrospective descriptive study of acute first admissions. Afr J Psychiatry. 2009;12:206–12.

Kigozi IM, Dobkin LM, Martin JN, Geng EH, Muyindike W, Emenyonu NI, et al. Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in sub-Saharan Africa. J Acquir Immune Defic Syndr. 2009;52:280–9.PubMedCrossRef

Girardi E, Sabin CA, Monforte AD. Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. J Acquir Immune Defic Syndr. 2007;46(Suppl 1):S3–8.PubMedCrossRef

10.

Mussini C, Manzardo C, Johnson M, Monforte AdA, Uberti-Foppa C, Antinori A, et al. Patients presenting with AIDS in the HAART era: a collaborative cohort analysis. AIDS. 2008;22:2461–9.PubMedCrossRef

11.

Bonjour MA, Montagne M, Zambrano M, Molina G, Lippuner C, Wadskier FG, et al. Determinants of late disease-stage presentation at diagnosis of HIV infection in Venezuela: a case-case comparison. AIDS Res Ther. 2008;5:6.PubMedCrossRef

12.

Carrizosa CM, Blumberg EJ, Hovell MF, Martinez-Donate AP, Garcia-Gonzalez G, Lozada R, et al. Determinants and prevalence of late HIV testing in Tijuana, Mexico. AIDS Patient Care STDS. 2010;24:333–40.PubMedCrossRef

13.

Chadborn TR, Delpech VC, Sabin CA, Sinka K, Evans BG. The late diagnosis and consequent short-term mortality of HIV-infected heterosexuals (England and Wales, 2000–2004). AIDS. 2006;20:2371–9.PubMedCrossRef

14.

Iliyasu Z, Abubakar IS, Kabir M, Aliyu MH. Knowledge of HIV/AIDS and attitude towards voluntary counseling and testing among adults. J Natl Med Assoc. 2006;98:1917–22.PubMed

15.

Hanna DB, Gupta LS, Jones LE, Thompson DM, Kellerman SE, Sackoff JE. AIDS-defining opportunistic illnesses in the HAART era in New York City. AIDS Care. 2007;19:264–72.PubMedCrossRef

16.

Lee JH, Kim GJ, Choi BS, Hong KJ, Heo MK, Kim SS, et al. Increasing late diagnosis in HIV infection in South Korea: 2000–2007. BMC Public Health. 2010;10:411.PubMedCrossRef

17.

Lemoh C, Guy R, Yohannes K, Lewis J, Street A, Biggs B, et al. Delayed diagnosis of HIV infection in Victoria 1994 to 2006. Sex Health. 2009;6:117–22.PubMedCrossRef

18.

Baker JV, Peng G, Rapkin J, Abrams DI, Silverberg MJ, MacArthur RD, et al. CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection. AIDS. 2008;22:841–8.PubMedCrossRef

19.

Moore RD, Keruly JC. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clin Infect Dis. 2007;44:441–6.PubMedCrossRef

20.

Taiwo BO, Li X, Palella F, Jacobson LP, Margolick JB, Detels R, et al. Higher risk of AIDS or death in patients with lower CD4 cell counts after virally suppressive HAART. HIV Med. 2009;10:657–60.PubMedCrossRef

21.

Aiuti F, Mezzaroma I. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART. AIDS Rev. 2006;8:88–97.PubMed

22.

Auld AF, Mbofana F, Shiraishi RW, Sanchez M, Alfredo C, Nelson LJ, et al. Four-year treatment outcomes of adult patients enrolled in Mozambique’s rapidly expanding antiretroviral therapy program. PLoS One. 2011;6:e18453.PubMedCrossRef

23.

Committee TUCHCS. Late diagnosis in the HAART era: proposed common definitions and associations with mortality. AIDS. 2010;24:723–7.

24.

Wolbers M, Bucher HC, Furrer H, Rickenbach M, Cavassini M, Weber R, et al. Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. HIV Med. 2008;9:397–405.PubMedCrossRef

25.

Plitt SS, Mihalicz D, Singh AE, Jayaraman G, Houston S, Lee BE. Time to testing and accessing care among a population of newly diagnosed patients with HIV with a high proportion of Canadian Aboriginals, 1998–2003. AIDS Patient Care STDS. 2009;23:93–9.PubMedCrossRef

26.

Bamford LP, Ehrenkranz PD, Eberhart MG, Shpaner M, Brady KA. Factors associated with delayed entry into primary HIV medical care after HIV diagnosis. AIDS. 2010;24:928–30.PubMedCrossRef

27.

Reed JB, Hanson D, McNaghten AD, Bertolli J, Teshale E, Gardner L, et al. HIV testing factors associated with delayed entry into HIV medical care among HIV-infected persons from eighteen states, United States, 2000–2004. AIDS Patient Care STDS. 2009;23:765–73.PubMedCrossRef

28.

Krawczyk CS, Funkhouser E, Kilby JM, Kaslow RA, Bey AK, Vermund SH. Factors associated with delayed initiation of HIV medical care among infected persons attending a southern HIV/AIDS clinic. South Med J. 2006;99:472–81.PubMedCrossRef

29.

Angotti N, Bula A, Gaydosh L, Kimchi EZ, Thornton RL, Yeatman SE. Increasing the acceptability of HIV counseling and testing with three C’s: convenience, confidentiality and credibility. Soc Sci Med. 2009;68:2263–70.PubMedCrossRef

30.

Bateganya M, Abdulwadud OA, Kiene SM. WITHDRAWN: home-based HIV voluntary counseling and testing in developing countries. Cochrane Database Syst Rev. 2010;2:CD006493.

31.

Wringe A, Isingo R, Urassa M, Maiseli G, Manyalla R, Changalucha J, et al. Uptake of HIV voluntary counselling and testing services in rural Tanzania: implications for effective HIV prevention and equitable access to treatment. Trop Med Int Health. 2008;13:319–27.PubMedCrossRef

32.

Chiang HC, Yu KL, Yap SF, Goh KK, Mo MH, Yang TW, et al. Awareness of HIV/AIDS prevention and acceptance of HIV testing among residents in Likoma Island, northern Malawi. Trans R Soc Trop Med Hyg. 2009;103:885–91.PubMedCrossRef

33.

Ulett KB, Willig JH, Lin H-Y, Routman JS, Abroms S, Allison J, et al. The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDs. 2009;23:41–9.PubMedCrossRef

34.

Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007;4:e298.PubMedCrossRef

35.

Krawczyk CS, Funkhouser E, Kilby JM, Vermund SH. Delayed access to HIV diagnosis and care: special concerns for the Southern United States. AIDS Care. 2006;18(Suppl 1):S35–44.PubMedCrossRef

36.

Mayben JK, Kramer JR, Kallen MA, Franzini L, Lairson DR, Giordano TP. Predictors of delayed HIV diagnosis in a recently diagnosed cohort. AIDS Patient Care STDS. 2007;21:195–204.PubMedCrossRef

37.

Mugavero MJ, Castellano C, Edelman D, Hicks C. Late diagnosis of HIV infection: the role of age and sex. Am J Med. 2007;120:370–3.PubMedCrossRef

38.

Krentz HB, Auld MC, Gill MJ. The high cost of medical care for patients who present late (CD4 <200 cells/microL) with HIV infection. HIV Med. 2004;5:93–8.PubMedCrossRef

39.

Antinori A, Johnson M, Moreno S, Rockstroh JK, Yazdanpanah Y. Introduction to late presentation for HIV treatment in Europe. Antivir Ther. 2010;15(Suppl 1):1–2.PubMedCrossRef

40.

Burns FM, Imrie JY, Nazroo J, Johnson AM, Fenton KA. Why the(y) wait? key informant understandings of factors contributing to late presentation and poor utilization of HIV health and social care services by African migrants in Britain. AIDS Care. 2007;19:102–8.PubMedCrossRef

41.

Smith RD, Delpech VC, Brown AE, Rice BD. HIV transmission and high rates of late diagnoses among adults aged 50 years and over. AIDS. 2010;24:2109–15.PubMedCrossRef

42.

Yazdanpanah Y, Lange J, Gerstoft J, Cairns G. Earlier testing for HIV—how do we prevent late presentation? Antivir Ther. 2010;15(Suppl 1):17–24.PubMedCrossRef

43.

Kivela PS, Krol A, Salminen MO, Ristola MA. Determinants of late HIV diagnosis among different transmission groups in Finland from 1985 to 2005. HIV Med. 2010;11:360–7.PubMed

44.

Longo B, Pezzotti P, Boros S, Urciuoli R, Rezza G. Increasing proportion of late testers among AIDS cases in Italy, 1996–2002. AIDS Care. 2005;17:834–41.PubMedCrossRef

45.

Brinkhof MW, Dabis F, Myer L, Bangsberg DR, Boulle A, Nash D, et al. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ. 2008;86:559–67.PubMedCrossRef

46.

Burack JH, Barrett DC, Stall RD, Chesney MA, Ekstrand ML, Coates TJ. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. JAMA. 1993;270:2568–73.PubMedCrossRef

47.

Burns FM, Johnson AM, Nazroo J, Ainsworth J, Anderson J, Fakoya A, et al. Missed opportunities for earlier HIV diagnosis within primary and secondary healthcare settings in the UK. AIDS. 2008;22:115–22.PubMedCrossRef

48.

Yang B, Chan SK, Mohammad N, Meyer JA, Risser J, Chronister KJ, et al. Late HIV diagnosis in Houston/Harris County, Texas, 2000–2007. AIDS Care. 2010;22:766–74.PubMedCrossRef

49.

Shorter MM, Ostermann J, Crump JA, Tribble AC, Itemba DK, Mgonja A, et al. Characteristics of HIV voluntary counseling and testing clients before and during care and treatment scale-up in Moshi, Tanzania. J Acquir Immune Defic Syndr. 2009;52:648–54.PubMedCrossRef

50.

Anderson M, Elam G, Gerver S, Solarin I, Fenton K, Easterbrook P. “It took a piece of me”: initial responses to a positive HIV diagnosis by Caribbean people in the UK. AIDS Care. 2010;22:1493–8.PubMedCrossRef

51.

Beer L, Fagan JL, Valverde E, Bertolli J. Health-related beliefs and decisions about accessing HIV medical care among HIV-infected persons who are not receiving care. AIDS Patient Care STDs. 2009;23:785–92.PubMedCrossRef

52.

Chida Y, Vedhara K. Adverse psychosocial factors predict poorer prognosis in HIV disease: a meta-analytic review of prospective investigations. Brain Behav Immun. 2009;23:434–45.PubMedCrossRef

53.

Genberg BL, Hlavka Z, Konda KA, Maman S, Chariyalertsak S, Chingono A, et al. A comparison of HIV/AIDS-related stigma in four countries: negative attitudes and perceived acts of discrimination towards people living with HIV/AIDS. Soc Sci Med. 2009;68:2279–87.PubMedCrossRef

54.

Luseno WK, Wechsberg WM. Correlates of HIV testing among South African women with high sexual and substance-use risk behaviours. AIDS Care. 2009;21:178–84.PubMedCrossRef

55.

MacPhail C, Pettifor A, Moyo W, Rees H. Factors associated with HIV testing among sexually active South African youth aged 15–24 years. AIDS Care. 2009;21:456–67.PubMedCrossRef

56.

Olley BO, Gxamza F, Seedat S, Theron H, Taljaard J, Reid E, et al. Psychopathology and coping in recently diagnosed HIV/AIDS patients—the role of gender. S Afr Med J. 2003;93:928–31.PubMed

57.

Vajpayee M, Mojumdar K, Raina M, Mishra S, Sreenivas V. HIV voluntary counseling and testing: an experience from India. AIDS Care. 2009;21:826–33.PubMedCrossRef

58.

Mukolo A, Wallston KA. The relationship between positive psychological attributes and psychological well-being in persons with HIV/AIDS. AIDS Behav. 2011 [Epub ahead of print].

59.

Martikainen P, Bartley M, Lahelma E. Psychosocial determinants of health in social epidemiology. Int J Epidemiol. 2002;31:1091–3.PubMedCrossRef

60.

Link BG, Phelan JC. Conceptualizing stigma. Annu Rev Sociol. 2001;27:363–85.CrossRef

61.

Mukolo A, Heflinger CA, Wallston KA. The stigma of childhood mental disorders: a conceptual framework. J Am Acad Child Adolesc Psychiatry. 2010;49:92–103; quiz 198.

62.

Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52:793–800.PubMedCrossRef

63.

Wester WC, Bussmann H, Koethe J, Moffat C, Vermund S, Essex M, et al. Adult combination antiretroviral therapy in sub-Saharan Africa: lessons from Bostwana and future challenges. HIV Ther. 2009;3:501–26.PubMedCrossRef

64.

Rosinska M. Current trends in HIV/AIDS epidemiology in Poland, 1999–2004. Eurosurveillance. 2006;11:94–7.

65.

Adler A, Mounier-Jack S, Coker RJ. Late diagnosis of HIV in Europe: definitional and public health challenges. AIDS Care. 2009;21:284–93.PubMedCrossRef

66.

del Rio C. Report from the 15th retrovirus conference: continued problems with late HIV diagnosis and new problems with testing scale-up. AIDS Clin Care. 2008;20:26–7.PubMedCrossRef

67.

World Health Organization. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva: WHO Press; 2007.

68.

Begovac J, Gedike K, Lukas D, Lepej SZ. Late presentation to care for HIV infection in Croatia and the effect of interventions during the Croatian Global Fund Project. AIDS Behav. 2008;12:S48–53.PubMedCrossRef

69.

Borghi V, Girardi E, Bellelli S, Angeletti C, Mussini C, Porter K, et al. Late presenters in an HIV surveillance system in Italy during the period 1992–2006. J Acquir Immune Defic Syndr. 2008;49:282–6.PubMedCrossRef

70.

Girardi E, Aloisi MS, Arici C, Pezzotti P, Serraino D, Balzano R, et al. Delayed presentation and late testing for HIV: demographic and behavioral risk factors in a multicenter study in Italy. J Acquir Immune Defic Syndr. 2004;36:951–9.PubMedCrossRef

71.

Balotta C, Bagnarelli P, Riva C, Valenza A, Antinori S, Colombo MC, et al. Comparable biological and molecular determinants in HIV type 1-infected long-term nonprogressors and recently infected individuals. AIDS Res Hum Retroviruses. 1997;13:337–41.PubMedCrossRef

72.

Marchetti G, Riva A, Cesari M, Bellistri GM, Gianelli E, Casabianca A, et al. HIV-infected long-term nonprogressors display a unique correlative pattern between the interleukin-7/interleukin-7 receptor circuit and T-cell homeostasis. HIV Med. 2009;10:422–31.PubMedCrossRef

73.

Castilla J, Sobrino P, De La Fuente L, Noguer I, Guerra L, Parras F. Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence. AIDS. 2002;16:1945–51.PubMedCrossRef

74.

Delpierre C, Dray-Spira R, Cuzin L, Marchou B, Massip P, Lang T, et al. Correlates of late HIV diagnosis: implications for testing policy. Int J STD AIDS. 2007;18:312–7.PubMedCrossRef

75.

Mojumdar K, Vajpayee M, Chauhan NK, Mendiratta S. Late presenters to HIV care and treatment, identification of associated risk factors in HIV-1 infected Indian population. BMC Public Health. 2010;10:416.PubMedCrossRef

76.

Chida Y, Steptoe A. Positive psychological well-being and mortality: a quantitative review of prospective observational studies. Psychosom Med. 2008;70:741–56.PubMedCrossRef

77.

Keiser O, Anastos K, Schechter M, Balestre E, Myer L, Boulle A, et al. Antiretroviral therapy in resource-limited settings to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. Trop Med Int Health. 1996;13:870–9.

78.

Diero LO, Shaffer D, Kimaiyo S, Siika AM, Rotich JK, Smith FE, et al. Characteristics of HIV infected patients cared for at “academic model for the prevention and treatment of HIV/AIDS” clinics in western Kenya. East Afr Med J. 2006;83:424–33.PubMed

79.

Mugusi SF, Mwita JC, Francis JM, Aboud S, Bakari M, Aris EA, et al. Effect of improved access to antiretroviral therapy on clinical characteristics of patients enrolled in the HIV care and treatment clinic, at Muhimbili National Hospital (MNH), Dar es Salaam, Tanzania. BMC Public Health. 2010;10:291.PubMedCrossRef

80.

Baratin D, Marceillac E, Trepo C, Cotte L, Peyramond D, Chidiac C, et al. Characteristics of patients diagnosed with AIDS shortly after first detection of HIV antibodies in Lyon University hospitals from 1985 to 2001. HIV Med. 2004;5:273–7.PubMedCrossRef

81.

Marcellin F, Abé C, Loubière S, Boyer S, Blanche J, Koulla-Shiro S, et al. Delayed first consultation after diagnosis of HIV infection in Cameroon. AIDS. 2009;23:1015–9.PubMedCrossRef

82.

Hocking JS, Rodger AJ, Rhodes DG, Crofts N. Late presentation of HIV infection associated with prolonged survival following AIDS diagnosis—characteristics of individuals. Int J STD AIDS. 2000;11:503–8.PubMedCrossRef

83.

Manavi K, McMillan A, Ogilvie M, Scott G. Heterosexual men and women with HIV test positive at a later stage of infection than homo- or bisexual men. Int J STD AIDS. 2004;15:811–4.PubMedCrossRef

84.

Nacher M, El Guedj M, Vaz T, Nasser V, Randrianjohany A, Alvarez F, et al. Risk factors for late HIV diagnosis in French Guiana. AIDS. 2005;19:727–9.PubMedCrossRef

85.

Manirankunda L, Loos J, Alou TA, Colebunders R, Nostlinger C. “It’s better not to know”: perceived barriers to HIV voluntary counseling and testing among sub-Saharan African migrants in Belgium. AIDS Educ Prev. 2009;21:582–93.PubMedCrossRef

86.

Wohl AR, Tejero J, Frye DM. Factors associated with late HIV testing for Latinos diagnosed with AIDS in Los Angeles. AIDS Care. 2009;21:1203–10.PubMedCrossRef

87.

Wong KH, Lee SS, Low KH, Wan WY. Temporal trend and factors associated with late HIV diagnosis in Hong Kong, a low HIV prevalence locality. AIDS Patient Care STDS. 2003;17:461–9.PubMedCrossRef

88.

Klein D, Hurley LB, Merrill D, Quesenberry CP Jr. Review of medical encounters in the 5 years before a diagnosis of HIV-1 infection: implications for early detection. J Acquir Immune Defic Syndr. 2003;32:143–52.PubMedCrossRef

89.

Bell C, Metsch LR, Vogenthaler N, Cardenas G, Rodriguez A, Locascio V, et al. Never in care: characteristics of HIV-infected crack cocaine users in 2 US cities who have never been to outpatient HIV care. J Acquir Immune Defic Syndr. 2010;54:376–80.PubMed

90.

Marsh KA, Reynolds GL, Rogala BE, Fisher DG, Napper LE. Who chooses a rapid test for HIV in Los Angeles County, California? Eval Health Prof. 2010;33:177–96.PubMedCrossRef

91.

Salovey P, Wegner DT. Communicating about health: message framing, persuasion and health behavior. In: Suls J, Wallston KA, editors. Social psychological foundations of health and illness. Calton: Blackwell; 2003. p. 54–81.CrossRef

92.

Baum A, Nesselhof SE. Psychological research and the prevention, etiology, and treatment of AIDS. Am Psychol. 1988;43:900–6.PubMedCrossRef

93.

Cleary PD, Van Devanter N, Rogers TF, Singer E, Shipton-Levy R, Steilen M, et al. Depressive symptoms in blood donors notified of HIV infection. Am J Public Health. 1993;83:534–9.PubMedCrossRef

94.

Owe-Larsson B, Sall L, Salamon E, Allgulander C. HIV infection and psychiatric illness. Afr J Psychiatry. 2009;12:115–28.

95.

Arendt G. Affective disorders in patients with HIV infection: impact of antiretroviral therapy. CNS Drugs. 2006;20:507–18.PubMedCrossRef

96.

Atkinson JH, Higgins JA, Vigil O, Dubrow R, Remien RH, Steward WT, et al. Psychiatric context of acute/early HIV infection. The NIMH Multisite Acute HIV Infection Study: IV. AIDS Behav. 2009;13:1061–7.PubMedCrossRef

97.

Berger S, Schad T, von Wyl V, Ehlert U, Zellweger C, Furrer H, et al. Effects of cognitive behavioral stress management on HIV-1 RNA, CD4 cell counts and psychosocial parameters of HIV-infected persons. AIDS. 2008;22:767–75.PubMedCrossRef

98.

Coleman CL, Eller LS, Nokes KM, Bunch E, Reynolds NR, Corless IB, et al. Prayer as a complementary health strategy for managing HIV-related symptoms among ethnically diverse patients. Holist Nurs Pract. 2006;20:65–72.PubMed

99.

Eller LS, Corless I, Bunch EH, Kemppainen J, Holzemer W, Nokes K, et al. Self-care strategies for depressive symptoms in people with HIV disease. J Adv Nurs. 2005;51:119–30.PubMedCrossRef

100.

Gore-Felton C, Koopman C, Spiegel D, Vosvick M, Brondino M, Winningham A. Effects of quality of life and coping on depression among adults living with HIV/AIDS. J Health Psychol. 2006;11:711–29.PubMedCrossRef

101.

Ironson G, Balbin E, Stuetzle R, Fletcher M, O’Cleirigh C, Laurenceau J, et al. Dispositional optimism and the mechanisms by which it predicts slower disease progression in HIV: proactive behavior, avoidant coping, and depression. Int J Behav Med. 2005;12:86–97.PubMedCrossRef

102.

Kaharuza FM, Bunnell R, Moss S, Purcell DW, Bikaako-Kajura W, Wamai N, et al. Depression and CD4 cell count among persons with HIV infection in Uganda. AIDS Behav. 2006;10:S105–11.PubMedCrossRef

103.

Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom Med. 2008;70:539–45.PubMedCrossRef

104.

Leserman J, Barroso J, Pence BW, Salahuddin N, Harmon JL. Trauma, stressful life events and depression predict HIV-related fatigue. AIDS Care. 2008;20:1258–65.PubMedCrossRef

105.

Lyketsos CG, Hoover DR, Guccione M, Dew MA, Wesch JE, Bing EG, et al. Changes in depressive symptoms as AIDS develop. The Multicenter AIDS Cohort Study. Am J Psychiatry. 1996;153:1430–7.PubMed

106.

Pence BW, Miller WC, Whetten K, Eron JJ, Gaynes BN. Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States. J Acquir Immune Defic Syndr. 2006;42:298–306.PubMedCrossRef

107.

Parsons JT, Rosof E, Mustanski B. Medication adherence mediates the relationship between adherence self-efficacy and biological assessments of HIV health among those with alcohol use disorders. AIDS Behav. 2008;12:95–103.PubMedCrossRef

108.

Brydon L, Walker C, Wawrzyniak AJ, Chart H, Steptoe A. Dispositional optimism and stress-induced changes in immunity and negative mood. Brain Behav Immun. 2009;23:810–6.PubMedCrossRef

109.

Hammer SM, Eron JJ Jr, Reiss P, Schooley RT, Thompson MA, Walmsley S, et al. Antiretroviral treatment of adult HIV infection recommendations of the International AIDS Society-USA panel. JAMA. 2008;300:555–70.PubMedCrossRef

110.

Nyblade L, Stangl A, Weiss E, Ashburn K. Combating HIV stigma in health care settings: what works? J Int AIDS Soc. 2009;12:15.PubMedCrossRef

111.

Mahajan AP, Sayles JN, Patel VA, Remien RH, Sawires SR, Ortiz DJ, et al. Stigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forward. AIDS. 2008;22(Suppl 2):S67–79.PubMedCrossRef

112.

Egger M, May M, Chene G, Phillips AN, Ledergerber B, Dabis F, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002;360:119–29.PubMedCrossRef

113.

Ounga T, Okinyi M, Onyuro S. Knowledge of HIV survival on skin-piercing instruments among young adults in Nyanza Province, Kenya. Int J STD AIDS. 2009;20:119.PubMedCrossRef

114.

Heckman TG, Kochman A, Sikkema KJ, Kalichman SC, Masten J, Goodkin K. Late middle-aged and older men living with HIV/AIDS: race differences in coping, social support, and psychological distress. J Natl Med Assoc. 2000;92:436–44.PubMed

115.

Alonzo AA, Reynolds NR. Stigma, HIV and AIDS: an exploration and elaboration of a stigma trajectory. Soc Sci Med. 1995;41:303–15.PubMedCrossRef

116.

Kalichman SC, Simbayi LC. HIV testing attitudes, AIDS stigma, and voluntary HIV counselling and testing in a black township in Cape Town, South Africa. Sex Transm Infect. 2003;79:442–7.PubMedCrossRef

117.

Kang SK, Chasteen AL. The development and validation of the age-based rejection sensitivity questionnaire. Gerontologist. 2009;49:303–16.PubMedCrossRef

118.

Richman LS, Leary MR. Reactions to discrimination, stigmatization, ostracism, and other forms of interpersonal rejection: a multimotive model. Psychol Rev. 2009;116:365–83.CrossRef

119.

Edwards GL, Barber BL. The relationship between rejection sensitivity and compliant condom use. Arch Sex Behav. 2009;39:1381–8.PubMedCrossRef

120.

Corrigan PW, Watson AC, Barr L. The self-stigma of mental illness: implications for self-esteem and self-efficacy. J Soc Clin Psychol. 2006;25:875–84.CrossRef

121.

Link BG, Cullen FT, Struening EL, Shrout PE, Dohrenwend BP. A modified labeling theory approach to mental disorders: an empirical assessment. Am Sociol Rev. 1989;54:400–23.CrossRef

122.

Kemeny ME. An interdisciplinary research model to investigate psychosocial cofactors in disease: application to HIV-1 pathogenesis. Brain Behav Immun. 2003;17(Suppl 1):S62–72.PubMedCrossRef

123.

Martin SC, Wolters PL, Klaas PA, Perez L, Wood LV. Coping styles among families of children with HIV infection. AIDS Care. 2004;16:283–92.PubMedCrossRef

124.

Makoae LN, Greeff M, Phetlhu RD, Uys LR, Naidoo JR, Kohi TW, et al. Coping with HIV-related stigma in five African countries. J Assoc Nurses AIDS Care. 2008;19:137–46.PubMedCrossRef

125.

Aday LA, Andersen R. A Framework for the study of access to medical care. Health Serv Res. 1974;9:208–20.PubMed

126.

Pescosolido BA, Gardner CB, Lubell KM. How people get into mental health services: stories of choice, coercion and “muddling through” from “first-timers”. Soc Sci Med. 1998;46:275–86.PubMedCrossRef

127.

Jones DL, Ross D, Weiss SM, Bhat G, Chitalu N. Influence of partner participation on sexual risk behavior reduction among HIV-positive Zambian women. J Urban Health. 2005;82:iv92–100.PubMedCrossRef

128.

Wallston KA, Wallston BS. Health locus of control scales. In: Lefcourt H, editor. Research of the locus of control construct. New York: Academic Press; 1981. p. 189–243.

129.

Wallston KA, Maides S, Wallston BS. Health-related information seeking as a function of health-related locus of control and health value. J Res Pers. 1976;10:215–22.CrossRef

130.

Kilic BG, Sener S. Family functioning and psychosocial characteristics in children with attention deficit hyperactivity disorder with comorbid oppositional defiant disorder or conduct disorder. Türk Psikiyatri Dergisi (Turk J Psychiatry). 2005;16:21–8.

131.

Hoang T, Goetz MB, Yano EM, Rossman B, Anaya HD, Knapp H, et al. The impact of integrated HIV care on patient health outcomes. Med Care. 2009;47:560–7.PubMedCrossRef

132.

Pearson CR, Micek MA, Pfeiffer J, Montoya P, Matediane E, Jonasse T, et al. One year after ART initiation: psychosocial factors associated with stigma among HIV-positive Mozambicans. AIDS Behav. 2009;13:1189–96.PubMedCrossRef

133.

Maughan-Brown B. Stigma rises despite antiretroviral roll-out: a longitudinal analysis in South Africa. Soc Sci Med. 2010;70:368–74.PubMedCrossRef

134.

Sengupta S, Banks B, Jonas D, Miles MS, Smith GC. HIV interventions to reduce HIV/AIDS stigma: a systematic review. AIDS Behav. 2011;15:1075–87.PubMedCrossRef

135.

Aracena-Genao B, Navarro J, Lamadrid-Figueroa H, Forsythe S, Trejo-Valdivia B. Costs and benefits of HAART for patients with HIV in a public hospital in Mexico. AIDS. 2008;22(Suppl):S141–8.PubMedCrossRef

136.

Lawn SD, Myer L, Bekker LG, Wood R. CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa. BMC Infect Dis. 2006;6:59.PubMedCrossRef

137.

Kaufmann GR, Furrer H, Ledergerber B, Perrin L, Opravil M, Vernazza P, et al. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy. Clin Infect Dis. 2005;41:361–72.PubMedCrossRef

138.

McKinnon LR, Kimani M, Wachihi C, Nagelkerke NJ, Muriuki FK, Kariri A, et al. Effect of baseline HIV disease parameters on CD4+ T cell recovery after antiretroviral therapy initiation in Kenyan women. PLoS One. 2010;5:e11434.PubMedCrossRef

139.

Antinori A, Johnson M, Moreno S, Yazdanpanah Y, Rockstroh JK. Report of a European Working Group on late presentation with HIV infection: recommendations and regional variation. Antivir Ther. 2010;15(Suppl 1):31–5.PubMedCrossRef

140.

Johnson M, Sabin C, Girardi E. Definition and epidemiology of late presentation in Europe. Antivir Ther. 2010;15(Suppl 1):3–8.PubMedCrossRef

141.

Moreno S, Mocroft A, Monforte A. Medical and societal consequences of late presentation. Antivir Ther. 2010;15(Suppl 1):9–15.PubMedCrossRef

142.

Thanawuth N, Chongsuvivatwong V. Late HIV diagnosis and delay in CD4 count measurement among HIV-infected patients in Southern Thailand. AIDS Care. 2008;20:43–50.PubMedCrossRef

143.

Dodd PJ, Garnett GP, Hallett TB. Examining the promise of HIV elimination by ‘test and treat’ in hyperendemic settings. AIDS. 2010;24:729–35.PubMedCrossRef

144.

Tayler-Smith K, Zachariah R, Massaquoi M, Manzi M, Pasulani O, van den Akker T, et al. Unacceptable attrition among WHO stages 1 and 2 patients in a hospital-based setting in rural Malawi: can we retain such patients within the general health system? Trans R Soc Trop Med Hyg. 2010;104:313–9.PubMedCrossRef

145.

McDonald AM, Li Y, Dore GJ, Ree H, Kaldor JM. Late HIV presentation among AIDS cases in Australia, 1992–2001. Aust N Z J Public Health. 2003;27:608–13.PubMedCrossRef

146.

de Paoli MM, Manongi R, Klepp KI. Factors influencing acceptability of voluntary counselling and HIV-testing among pregnant women in Northern Tanzania. AIDS Care. 2004;16:411–25.PubMedCrossRef

147.

McLeroy KR, Bibeau D, Steckler A, Glanz K. An ecological perspective on health promotion programs. Health Educ Q. 1988;15:351–77.PubMedCrossRef

148.

Janz NK, Champion VL, Strecher VJ. The health belief model. In: Glanz K, Rimer BK, Lewis FM, editors. Health behavior and health education: theory, research, and practice. 3rd ed. San Francisco: Jossey-Bass; 2002. p. 45–66.

149.

Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50:179–211.CrossRef

150.

Rogers RW. Cognitive and physiological processes in fear appeals and attitude change: a revised theory of protection motivation. In: Cacioppo JT, Petty RE, editors. Social psychophysiology: a sourcebook. New York: The Guildford Press; 1983. p. 153–76.

151.

Grispen JE, Ronda G, Dinant GJ, de Vries NK, van der Weijden T. To test or not to test: a cross-sectional survey of the psychosocial determinants of self-testing for cholesterol, glucose, and HIV. BMC Public Health. 2011;11:112.PubMedCrossRef

Titel: Predictors of Late Presentation for HIV Diagnosis: A Literature Review and Suggested Way Forward
verfasst von: Abraham Mukolo
Raquel Villegas
Muktar Aliyu
Kenneth A. Wallston
Publikationsdatum: 01.01.2013
Verlag: Springer US
Erschienen in: AIDS and Behavior / Ausgabe 1/2013
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-011-0097-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2013

Effect of a Clinic-Wide Social Marketing Campaign to Improve Adherence to Antiretroviral Therapy for HIV Infection

Medication Persistence of HIV-infected Drug Users on Directly Administered Antiretroviral Therapy

Evidence for the Reliability and Validity of the Internalized AIDS-Related Stigma Scale in Rural Uganda

Adherence to Hepatitis C Virus Therapy in HIV/Hepatitis C-Coinfected Patients

Correlates of Stigma among Rural Indian Women Living with HIV/AIDS